Newman Christy E, Mao Limin, Persson Asha, Holt Martin, Slavin Sean, Kidd Michael R, Post Jeffrey J, Wright Edwina, de Wit John
1 Centre for Social Research in Health , UNSW Australia, Sydney, Australia .
AIDS Patient Care STDS. 2015 May;29(5):267-78. doi: 10.1089/apc.2014.0301. Epub 2015 Mar 25.
Current debates regarding the use of antiretroviral therapy (ART) to promote both individual- and population-level health benefits underscore the importance of understanding why a subpopulation of people with diagnosed HIV and access to treatment choose not to use it. Semi-structured interviews were conducted between 2012 and 2014 with 27 people living with HIV in Australia who were not using ART at the time of interview. Analytic triangulation permitted an appreciation of not only the varied personal reasons for non-use of treatment, but also underlying views on HIV treatment, and the ideal conditions imagined necessary for treatment initiation. Policy goals to increase the number of people with HIV using ART must recognize the diverse explanations for non-use of ART, which include concerns about the various impacts of committing to lifelong pharmaceutical treatment use. Our research identified distinctive subgroups among people who are not using antiretroviral therapy, with a range of individual and social needs that may affect treatment decisions. These findings challenge assumptions about treatment non-use in resource-rich settings, revealing persistent consumer fears about the potent and unknown effects of HIV medications that deserve greater recognition in policy debate on treatment uptake.
当前关于使用抗逆转录病毒疗法(ART)以促进个人和群体层面健康益处的争论,凸显了理解为何一部分已确诊感染艾滋病毒且有机会接受治疗的人群选择不使用该疗法的重要性。2012年至2014年间,对澳大利亚27名艾滋病毒感染者进行了半结构化访谈,这些人在访谈时未使用抗逆转录病毒疗法。分析三角剖分法不仅有助于理解不使用治疗的各种个人原因,还能了解对艾滋病毒治疗潜在的看法,以及启动治疗所需的理想条件。旨在增加使用抗逆转录病毒疗法的艾滋病毒感染者人数的政策目标,必须认识到不使用抗逆转录病毒疗法的多种原因,其中包括对终身药物治疗的各种影响的担忧。我们的研究在未使用抗逆转录病毒疗法的人群中识别出了不同的亚组,他们有一系列可能影响治疗决策的个人和社会需求。这些发现挑战了在资源丰富环境中关于不使用治疗的假设,揭示了消费者对艾滋病毒药物强大且未知影响的持续恐惧,而这在关于治疗采用的政策辩论中值得得到更多认可。